Ticker Sage

Form 4 · BMY

Bristol Myers Squibb General Counsel Cari Gallman reports exercising or converting 4,559 shares

Cari Gallman, Bristol Myers Squibb's EVP, General Counsel, filed a Form 4 on Oct 5, 2026 at 4:18 PM ET reporting transactions on Oct 2, 2026.

The filing reports 4,559 shares in an exercise or conversion of a derivative security (code M); and 2,332 shares withheld to pay the exercise price or tax (code F).

After these transactions, the filing lists 15,876 shares of Common Stock, $0.10 par value held directly.

Effect on holdings

Taken together, the rows reported here raised Cari Gallman's directly held shares by 16.3%, from 13,649 to 15,876.

Reporting person

Transactions as reported

DateCodeSecuritySharesPriceAcquired or disposedHeld afterOwnership
2026-10-02MCommon Stock, $0.10 par value4,559Acquired18,208Direct
2026-10-02FCommon Stock, $0.10 par value2,332$61.15Disposed15,876Direct
2026-10-02MRestricted Stock Units (derivative)4,559Disposed0Direct

Codes: P purchase, S sale, A grant or award, M/X/C exercise or conversion, F shares withheld for taxes or the exercise price, G gift. Prices are as reported; some are weighted averages of several trades.

Source

Bristol Myers Squibb company file → · More Bristol Myers Squibb filings

Disclosures

Editor holdings in BMY
The editor holds no position in Bristol Myers Squibb (BMY). As of Oct 25, 2026.
Last updated
Oct 25, 2026

A summary of a public filing for general education, the same for every reader. Not a recommendation to buy, sell or hold BMY.